These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25363759)
21. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. Hastings GA; Coleman TA; Haudenschild CC; Stefansson S; Smith EP; Barthlow R; Cherry S; Sandkvist M; Lawrence DA J Biol Chem; 1997 Dec; 272(52):33062-7. PubMed ID: 9407089 [TBL] [Abstract][Full Text] [Related]
22. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop. Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954 [TBL] [Abstract][Full Text] [Related]
23. Expression, purification, and functional characterization of the serine protease inhibitor neuroserpin expressed in Drosophila S2 cells. Hill RM; Brennan SO; Birch NP Protein Expr Purif; 2001 Aug; 22(3):406-13. PubMed ID: 11483002 [TBL] [Abstract][Full Text] [Related]
25. An integrated approach to the analysis and modeling of protein sequences and structures. III. A comparative study of sequence conservation in protein structural families using multiple structural alignments. Yang AS; Honig B J Mol Biol; 2000 Aug; 301(3):691-711. PubMed ID: 10966778 [TBL] [Abstract][Full Text] [Related]
26. Expanding the nitrogen regulatory protein superfamily: Homology detection at below random sequence identity. Kinch LN; Grishin NV Proteins; 2002 Jul; 48(1):75-84. PubMed ID: 12012339 [TBL] [Abstract][Full Text] [Related]
27. Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB. Belorgey D; Sharp LK; Crowther DC; Onda M; Johansson J; Lomas DA Eur J Biochem; 2004 Aug; 271(16):3360-7. PubMed ID: 15291813 [TBL] [Abstract][Full Text] [Related]
28. Serpin mutagenesis. Antalis TM; Lawrence DA Methods; 2004 Feb; 32(2):130-40. PubMed ID: 14698625 [TBL] [Abstract][Full Text] [Related]
29. The crystal structure of plasminogen activator inhibitor 2 at 2.0 A resolution: implications for serpin function. Harrop SJ; Jankova L; Coles M; Jardine D; Whittaker JS; Gould AR; Meister A; King GC; Mabbutt BC; Curmi PM Structure; 1999 Jan; 7(1):43-54. PubMed ID: 10368272 [TBL] [Abstract][Full Text] [Related]
30. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities. Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170 [TBL] [Abstract][Full Text] [Related]
31. Detection of truncated isoforms of human neuroserpin lacking the reactive center loop: Implications in noninhibitory role. Fatima S; Ansari S; Bano S; Ahamad S; Ishqi HM; Tabish M; Gupta D; Rehman SU; Jairajpuri MA IUBMB Life; 2021 Jul; 73(7):941-952. PubMed ID: 33893722 [TBL] [Abstract][Full Text] [Related]
32. Embelin binds to human neuroserpin and impairs its polymerisation. Saga G; Sessa F; Barbiroli A; Santambrogio C; Russo R; Sala M; Raccosta S; Martorana V; Caccia S; Noto R; Moriconi C; Miranda E; Grandori R; Manno M; Bolognesi M; Ricagno S Sci Rep; 2016 Jan; 6():18769. PubMed ID: 26732982 [TBL] [Abstract][Full Text] [Related]
33. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries. Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091 [TBL] [Abstract][Full Text] [Related]
34. Contrasting conformational dynamics of β-sheet A and helix F with implications in neuroserpin inhibition and aggregation. Ansari S; Ray A; Ali MF; Bano S; Jairajpuri MA Int J Biol Macromol; 2021 Apr; 176():117-125. PubMed ID: 33516851 [TBL] [Abstract][Full Text] [Related]
35. Human T cell activation induces synaptic translocation and alters expression of the serine protease inhibitor neuroserpin and its target protease. Lorenz N; Loef EJ; Verdon DJ; Chen CJ; Mansell CJ; Angel CE; Brooks AE; Dunbar PR; Birch NP J Leukoc Biol; 2015 Apr; 97(4):699-710. PubMed ID: 25670787 [TBL] [Abstract][Full Text] [Related]
36. A study of the oxidation-induced conformational and functional changes in neuroserpin. Mohsenifar A; Lotfi AS; Ranjbar B; Allameh A; Zaker F; Hasani L; Batool EK; Hasannia S Iran Biomed J; 2007 Jan; 11(1):41-46. PubMed ID: 18051703 [TBL] [Abstract][Full Text] [Related]
37. Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell-cell interactions in the pathophysiology of neurological disease. Godinez A; Rajput R; Chitranshi N; Gupta V; Basavarajappa D; Sharma S; You Y; Pushpitha K; Dhiman K; Mirzaei M; Graham S; Gupta V Cell Mol Life Sci; 2022 Mar; 79(3):172. PubMed ID: 35244780 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease. Stone SR; Le Bonniec BF J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048 [TBL] [Abstract][Full Text] [Related]
39. Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1. Blouse GE; Perron MJ; Kvassman JO; Yunus S; Thompson JH; Betts RL; Lutter LC; Shore JD Biochemistry; 2003 Oct; 42(42):12260-72. PubMed ID: 14567688 [TBL] [Abstract][Full Text] [Related]
40. New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Yepes M; Lawrence DA Exp Biol Med (Maywood); 2004 Dec; 229(11):1097-104. PubMed ID: 15564435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]